Why is Emmessar Biotech falling/rising?

As of 29-Sep, Emmessar Biotech & Nutrition Ltd's stock is currently priced at Rs 32.20, reflecting a decline of Rs 1.75 or 5.15%. The stock has been underperforming, having fallen for three consecutive days, resulting in a total decline of 9.07% during this period. It opened with a loss of 2% today and reached an intraday low of Rs 32.01, indicating significant selling pressure. Additionally, the stock's delivery volume has drastically decreased by 92.39% compared to its 5-day average, suggesting a lack of investor interest. Over the past week, the stock has dropped by 9.96%, while its year-to-date performance shows a decline of 30.45%, indicating a challenging environment for the company.
Broader Market Context: In comparison to the benchmark Sensex, which has decreased by 2.18% over the past week, Emmessar Biotech's performance has been notably worse. The stock's recent decline contrasts sharply with its 1-month return of 22.20%, which was significantly better than the Sensex's 0.70% increase, highlighting a recent reversal in momentum. The broader market context suggests that while the stock had a strong performance in the preceding month, it is currently facing headwinds that are contributing to its decline, particularly in light of the overall market's relatively stable performance.